Triazine dna modifiers
AssigneeAuspex Pharmaceuticals, Inc.
InventorsThomas G. Gant, Sepehr Sarshar
Life of this patent
Estimating the term…
Abstract
The present invention relates to new triazine DNA modifiers, pharmaceutical compositions thereof, and methods of use thereof
Claims36
A compound of structural Formula I
- or a pharmaceutically acceptable salt thereof, wherein:
- R1-R18 are independently selected from the group consisting of hydrogen and deuterium;
- at least one of R1-R18 is deuterium;
- if R1-R3, are deuterium, then at least one of R4-R18 is deuterium;
- if R1-R3, R7-R9, and R13-R15 are deuterium, then at least one of R4-R6, and R16-R18 is deuterium;
- and
- R1-R18 are not all deuterium.
A pharmaceutical composition comprising a pharmaceutically acceptable carrier together with a compound of structural Formula I
- or a pharmaceutically acceptable salt thereof, wherein:
- R1-R18 are independently selected from the group consisting of hydrogen and deuterium;
- and
- at least one of R1-R18 is deuterium.
A method of treatment of a neoplastic mediated-disorder comprising the administration, to a patient in need thereof, of a therapeutically effective amount of a compound of structural Formula I
- or a pharmaceutically acceptable salt thereof, wherein:
- R1-R18 are independently selected from the group consisting of hydrogen and deuterium;
- and
- at least one of R1-R18 is deuterium.
A compound, for use as a medicament, having structural Formula I
- or a pharmaceutically acceptable salt thereof, wherein:
- R1-R18 are independently selected from the group consisting of hydrogen and deuterium;
- and
- at least one of R1-R18 is deuterium.
A compound for use in the manufacture of a medicament for the prevention or treatment of a disorder ameliorated by the modification of DNA, said compound having structural Formula I
- or a pharmaceutically acceptable salt thereof, wherein:
- R1-R18 are independently selected from the group consisting of hydrogen and deuterium;
- and
- at least one of R1-R18 is deuterium.
Dependencies are inferred from the claim text.